Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

GELS

Gelteq Ltd

Nov 26 • 11:29AM ET

1.07

-0.02 -1.84 %

Healthcare • Drug Manufacturers - Specialty & Generic • Australia • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.37	Insider Own	60.36%	Shs Outstand	9.44M	Perf Week	17.29%
Market Cap	10.10M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	3.74M	Perf Month	-12.30%
Enterprise Value	12.63M	PEG	-	EPS next Q	-	Inst Own	1.00%	Short Float	0.07%	Perf Quarter	-17.70%
Income	-4.30M	P/S	91.82	EPS this Y	-	Inst Trans	7.64%	Short Ratio	0.00	Perf Half Y	-36.32%
Sales	0.11M	P/B	1.04	EPS next Y	-	ROA	-	Short Interest	0.00M	Perf YTD	-53.88%
Book/sh	1.03	P/C	43.91	EPS next 5Y	-	ROE	-	52W High	5.50 -80.55%	Perf Year	-41.54%
Cash/sh	0.02	P/FCF	-	EPS past 3/5Y	-18.35% -	ROIC	-41.52%	52W Low	0.77 38.93%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.09% -	Gross Margin	-863.65%	Volatility	16.30% 8.93%	Perf 5Y	-
Dividend TTM	-	EV/Sales	114.82	EPS Y/Y TTM	-	Oper. Margin	-3267.80%	ATR (14)	0.12	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.27	Sales Y/Y TTM	-	Profit Margin	-4095.62%	RSI (14)	49.24	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.27	EPS Q/Q	-	SMA20	3.39%	Beta	-0.80	Target Price	-
Payout	-	Debt/Eq	0.27	Sales Q/Q	-	SMA50	-10.45%	Rel Volume	0.12	Prev Close	1.09
Employees	18	LT Debt/Eq	0.00	Earnings	-	SMA200	-27.86%	Avg Volume	2.18M	Price	1.07
IPO	Oct 29, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	86,571	Change	-1.84%

Nov-24-25 08:30AM	Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform (GlobeNewswire) +20.39%
Oct-23-25 09:00AM	Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform (GlobeNewswire) +23.01%
Oct-09-25 08:00AM	Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound (GlobeNewswire) +6.25%
Sep-12-25 07:30AM	Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner (GlobeNewswire) +6.67%
Sep-05-25 11:26AM	Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market (GlobeNewswire) +62.50%
10:30AM	Loading…
10:30AM	BC-Most Active Stocks (Associated Press Finance)
Sep-04-25 08:35AM	Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs (ACCESSWIRE) -14.29%
Jul-17-25 08:30AM	Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities (GlobeNewswire) +10.00%
Jun-10-25 07:30AM	Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner (GlobeNewswire) +73.53%
May-03-25 11:00AM	Ford, Disney, And AMD To Report Results Next Week (Seeking Alpha)
Feb-27-25 08:45AM	Gelteq's Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand (GlobeNewswire)
Feb-04-25 08:00AM	Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC (GlobeNewswire)
Jan-24-25 08:00AM	Gelteq Appoints Matthew Jones as Head of Sports Performance (GlobeNewswire)
Dec-19-24 08:30AM	Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology (GlobeNewswire) +21.97%
Dec-17-24 08:30AM	Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug (GlobeNewswire) +5.79%
08:30AM	Loading…
Dec-09-24 08:30AM	Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference (GlobeNewswire) +78.00%
Dec-02-24 08:30AM	Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand (GlobeNewswire) +91.02%
Nov-26-24 08:30AM	Gelteq Announces 400,000 Units Enter into Production in November 2024 (GlobeNewswire)
Nov-12-24 09:00AM	Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business (GlobeNewswire)
Oct-30-24 10:00AM	Gelteq Limited Closes US$5.2 Million Initial Public Offering (GlobeNewswire) -19.40%
Oct-28-24 09:50PM	Gelteq Limited Prices US$5.2 Million Initial Public Offering (GlobeNewswire)

Gelteq Ltd. operates as a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The firm also offers edible gels. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Black Swan Sale

50% Off Elite

GELS

Gelteq Ltd

Upgrade your FINVIZ experience